Primary Record
Trityllosartan
- In stock
- 7,938 g
- Purity
- 98.9 %
- CAS
- 133909-99-6
Compound Identifiers & Properties
- CAS
- 133909-99-6
- PubChem CID
- 10865273
- SMILES
- CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN(N=N4)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)CO)Cl
- Canonical SMILES
- CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cc1
Names & Synonyms
- Trityllosartan
- Trityl losartan
- N-Trityl Losartan
- N-Trityllosartan
- N2-Trityllosartan
- 133909-99-6
- Iosartan
- Losartan EP Impurity H
- N-Trityl Losartan-d4
- N0UJG23A3Y
- triphenylmethyl Losartan
- UNII-N0UJG23A3Y
- RefChem:900641
- Losartan potassium impurity H
- ACMC-20mv58
- C41H37ClN6O
- DTXSID80158417
- MFCD09028113
- QQPGGBNMTNDKEY-UHFFFAOYSA-N
- SCHEMBL3407499
- DTXCID5080908
- Losartan potassium impurity H [EP]
- CTK4B8860
- Losartan potassium impurity H[EP]
- (2-Butyl-4-chloro-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)methanol
- BCP12002
- JCC28324
- AKOS015895667
- ZINC150341103
- AC-1071
- CID10865273
- EC 412-420-5
- N-Trityl Losartan (Losartan Impurity H)
- AN-15299
- BC214801
- 2-CHLORO-3,3-DIETHOXYPROP-1-ENE
- J629.052C
- [2-butyl-5-chloro-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- FT-0656123
- NS00003947
- 909B996
- A806695
- LOSARTAN POTASSIUM IMPURITY H(EP IMPURITY)
- LOSARTAN POTASSIUM IMPURITY H[EP IMPURITY]
- I06-1106
- LOSARTAN POTASSIUM IMPURITY H [EP IMPURITY]
- Q27284359
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(2-(triphenylmethyl)-2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
- 2-Butyl-4-chloro-5-hydroxymethyl-1-((2'-(1H-2-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole
- 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-(2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl)-1H-imidazole
- [2-Butyl-4-chloro-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methanol
- 1309283-24-6
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
- 1H-Imidazole-5-methanol,2-butyl-4-chloro-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
- 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole
- 2-n-butyl-4-chloro-1-[(2'-(2-triphenylmethyl-2H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-1H-imidazole-5-methanol
- [2-butyl-4-chloro-1-({2'-[2-(triphenylmethyl)-2H-1,2,3,4-tetrazol-5-yl]-[1,1'-biphenyl]-4-yl}methyl)-1H-imidazol-5-yl]methanol
- [2-Butyl-4-chloro-1-({2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl}methyl)-1H-imidazol-5-yl]methanol
- [2-Butyl-5-chloro-3-[[2,3,5,6-tetradeuterio-4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- [2-butyl-5-chloro-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- 124751-00-4
- 2-(2-Trityl-2H-tetrazole-5-yl)-4 -[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazole-1-ylmethyl]biphenyl
- 2-Butyl-4-chloro-1-[[2 -(2-trityl-2H-tetrazol-5-yl)-1,1 -biphenyl-4-yl]methyl]-1H-imidazole-5-methanol
- 2-Butyl-4-chloro-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol
- 2-Butyl-4-chloro-1-[2 -(2-trityl-2H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-imidazole-5-methanol
- 2-Butyl-4-chloro-1-[2'-(2-trityl-2H-tetrazole-5-yl)biphenyl-4-yl-methyl]-1H-imidazole-5-yl-methanol
- 2-n-butyl-4-chloro-1-[(2'-(2-triphenylmethyl-2H-tetrazol-5-yl) -1,1'-biphenyl-4-yl)methyl]-1H-imidazole-5-methanol
- 2-n-Butyl-4-chloro-1-[(2'-(2-triphenylmethyl-2H-tetrazol-5-yl)-1,1'-biphenyl -4-yl)methyl]-1H-imidazole-5-methanol
- 2-n-Butyl-4-chloro-1-[(2'-(2-triphenylmethyl-2H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]1H-imidazole-5-methanol
- 412-420-5
- 603-776-4
- Losartan Potassium Imp. H (EP); Losartan Imp. H (EP); [2-Butyl-4-chloro-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methanol; Losartan Potassium Impurity H; Losartan Impurity H